Table 3.
The BsmI effect odds ratios stratified by anatomical site
| Model | Colon cancer | Rectal cancer | ||||
| Total No. cases/controls | OR (95% CI) | P value1 | Total No. cases/controls | OR (95% CI) | P value1 | |
| Codominant (BB vs bb) | 1365/1581 | 0.80 (0.68-0.93) | 0.004/0.21 | 659/790 | 0.92 (0.73-1.15) | 0.46/0.90 |
| Codominant (Bb vs bb) | 2257/2438 | 0.99 (0.88-1.12) | 0.92/0.95 | 1029/1240 | 0.94 (0.80-1.11) | 0.48/0.21 |
| Codominant (B vs b) | 5328/5972 | 0.91 (0.84-0.98) | 0.01/0.25 | 2440/2966 | 0.95 (0.85-1.06) | 0.38/0.99 |
| Dominant (BB + Bb vs bb) | 2664/2986 | 0.94 (0.84-1.05) | 0.25/0.65 | 1220/1483 | 0.94 (0.77-1.16) | 0.59/0.40 |
| Recessive (BB vs Bb + bb) | 2664/2986 | 0.80 (0.69-0.92) | 0.002/0.19 | 1220/1483 | 0.93 (0.80-1.09) | 0.40/0.51 |
1
Test for overall effect and heterogeneity, respectively. OR: Odds ratios.